Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tebipenem pivoxil granules

A technology of tipipenem and granules, which is applied in the field of pharmaceutical preparations, can solve problems such as increased water content, increased polymers, and poor dissolution of granules, and achieves low impurities and polymers, high compatibility, and good Dissolution effect

Inactive Publication Date: 2012-12-26
SHANDONG LUOXIN PARMACEUTICAL GROUP STOCK CO LTD
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the poor stability of tipipenem pivoxate, the related substances increase greatly under high temperature and high humidity conditions, so the selection and dosage of excipients become particularly important. Random selection of excipients may make tipipenem pivoxate granules The dissolution rate of the agent becomes worse, the related substances increase, the content decreases, the polymer increases, the moisture content rises, etc., and even cannot be granulated

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tebipenem pivoxil granules
  • Tebipenem pivoxil granules
  • Tebipenem pivoxil granules

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Embodiment 1: the selection of preparation method

[0022] 1. Granulation method

[0023] According to the prescription of tipipenem pivoxil granules of the present invention, dry granulation and wet granulation were used respectively, and then the finished product was tested for related substances (i.e. impurities). The results are shown in Table 1.

[0024] Table 1 Test results of related substances in wet granulation and dry granulation

[0025]

[0026] It can be seen from the test results that the wet granulation process increases the impurities much more than the dry granulation process, so the dry granulation process is more suitable.

[0027] 2. Selection of dry granulation conditions

[0028] Raw material crushing particle size:

[0029] Tipipenem pivoxate is a crystalline powder. In order to mix evenly with auxiliary materials, the particle size should be kept in the same range as possible. The pulverized tipipenem pivoxate of the present invention is pa...

Embodiment 2

[0039] Embodiment 2: different proportioning tests of main and auxiliary materials

[0040] 1. Different contents of microcrystalline cellulose and sucrose

[0041] According to the prescription in Table 4, dry granulation was performed, and then the granulation condition, granule fluidity, angle of repose, granule strength, mouthfeel, and water content were used as inspection indicators for testing. The results are shown in Table 5.

[0042] Table 4 Prescriptions with different contents of microcrystalline cellulose and sucrose

[0043] Main and auxiliary materials

Prescription 1

Prescription 2

Prescription 3

Prescription 4

Prescription 5

tipipenem pivoxate

12.976g

12.976g

12.976g

12.976g

12.976g

microcrystalline cellulose

62.50g

50.00g

37.50

25.00g

12.50g

sucrose

24.524g

37.024g

49.524g

62.024g

74.424g

aspartame

1.00g

...

Embodiment 3

[0059] Embodiment 3: Preparation of tipipenem pivoxil granules of the present invention

[0060] According to the prescription of tipipenem pivoxil granule of the present invention, i.e. 32.44 parts by weight of tipipenem pivoxil, 31.25 parts by weight of microcrystalline cellulose, 183.56 parts by weight of sucrose, 2.5 parts by weight of Spartan and 0.25 parts by weight of red iron oxide (or 12.976 parts by weight of tipipenem pivoxil, 12.50 parts by weight of microcrystalline cellulose, 73.424 parts by weight of sucrose, 1.00 parts by weight of aspartame and 0.1 parts by weight red iron oxide), three batches of tipipenem pivoxil granules were prepared by dry granulation (hereinafter referred to as batch 100601, batch 100602, batch 100603), and the yields were 86.80% and 86.26% respectively , 86.60%.

[0061] Dry granulation process steps:

[0062] In an environment with a relative humidity below 60%, crush the above raw and auxiliary materials through an 80-mesh sieve, mi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of chemical synthesis, and discloses a tebipenem pivoxil granule. The granule disclosed by the invention consists of 32.44 weight parts of tebipenem pivoxil, 31.25 weight parts of microcrystalline cellulose, 183.56 weight parts of cane sugar, 2.5 weight parts of aspartame and 0.25 weight parts of red iron oxide. According to the invention, the novel granule is obtained by adopting four auxiliary materials which have varieties of sources and are well compatible with the main drug, namely the tebipenem pivoxil. The granule disclosed by the invention has the advantages that higher dissolution rate, lower impurity rate and lower polymerizability can be still guaranteed even under the circumstance that less auxiliary materials are adopted, so the granule has higher quality and can be widely applied to clinical treatment.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to tipipenem pivoxil granules. Background technique [0002] Tipipenem pivate, the chemical name is (+)-(4R,5S,6S)-6-[(1R)-hydroxyethyl]-4-methyl-7-oxo-3[[1- (2-Thiazolin-2-yl)-3-azetidinyl]sulfur]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (2,2-dimethyl -1-oxopropoxy) methyl ester belongs to carbapenem antibiotics, and its structural formula is as follows: [0003] [0004] Tipipenem pivoxil was first developed by Pfizer of the United States, and the fine-grained tipipenem pivoxil was developed by Japan Meiji Company. It was approved by Japan in February 2009 and launched in April 2009. There are listed manufacturers and related reports. Tipipenem pivoxate fine granule is used for the treatment of ear, nose, throat and upper respiratory tract infections in pediatric patients. Southern drugs. Tipipenem pivoxil has a broad antibacterial spectrum. For most clini...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/16A61K31/427A61K47/38A61P31/04
Inventor 刘明霞牛洪芬刘文文杨丽娟
Owner SHANDONG LUOXIN PARMACEUTICAL GROUP STOCK CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com